Moderate U.S. consumer spending, inflation support rate cut
July 30, 2019Mylan reaches $30 million settlement in SEC’s EpiPen probe
July 30, 2019Cancer drug Keytruda, vaccines propel Merck to quarterly profit beat
at
Merck & Co Inc reported higher-than-expected second-quarter profit and revenue and raised its full-year earnings forecast on Tuesday, powered by strong demand for its blockbuster cancer immunotherapy Keytruda and vaccine sales.
Powered by WPeMatico
